Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells

American Journal of Pathology

Volumn 160, Issue 4, 2002, Pages 1521-1528

  Thomas, Roman Kurt ^a   Kallenborn, Anne ^a   Wickenhauser, Claudia ^a   Schultze, Joachim Ludwig ^b,c   Draube, Andreas ^a   Vockerodt, Martina ^a   Re, Daniel ^a   Diehl, Volker ^a   Wolf, Jürgen ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; GENE PRODUCT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS INHIBITION; REED STERNBERG CELL; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 0036105506     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62578-3     Document Type: Article

References (48)

1. The Fas death factor
2. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
3. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
4. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative disorder
5. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity
6. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis
7. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
8. Inhibition of death receptor signals by cellular FLIP
9. The role of c-FLIP in modulation of CD95-induced apoptosis
10. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes
11. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
12. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
13. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP
14. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells
15. Flice-inhibitory protein is a key regulator of germinal center B cell apoptosis
16. Cutting edge: Cellular Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein protects germinal center B cells from apoptosis during germinal center reactions
17. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease
18. Clonal selection and learning in the antibody system
19. Protection against Fas-dependent Th1 mediated apoptosis by antigen receptor engagement in B-cells
20. Fas expression and apoptosis in human B cells
21. Hodgkin and Reed Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
22. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
23. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells
24. Down-regulation of BOB1/OBF1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription
25. Detection of identical Hodgkin-Reed Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later
26. Clonal relapse in Hodgkin's disease
27. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas
28. Expression of Fas and Fas ligand in Hodgkin's disease
29. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95
30. Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells
31. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction
32. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma gives rise to permanently growing Hodgkin-Reed Sternberg cells
33. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient
34. Establishment of a malignant, Epstein-Barr-virus (EBV)-negative cell-line from the pleural effusion of a patient with Hodgkin's disease
35. Rearrangement, hypermutation, and possible preferential use of a VH5 gene, VH32, in a Hodgkin's cell line
36. Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: Activation of immature lymphoid cells in Hodgkin's disease
37. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
38. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression
39. Resistance to Fas-mediated apoptosis in human hepatoma cells
40. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease
41. Single-cell analysis of the t(14; 18)(q32; q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells
42. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease
43. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines
44. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
45. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
46. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells
47. Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma
48. Activation of NF-kappaB by FADD, Casper, and caspase-8